scholarly article | Q13442814 |
P50 | author | Thomas E. Starzl | Q1248240 |
John Julian Fung | Q61476062 | ||
P2093 | author name string | D G Kim | |
S Todo | |||
N Murase | |||
D V Cramer | |||
P2860 | cites work | FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics | Q28338447 |
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine | Q33993321 | ||
Orthotopic liver transplantation in dogs receiving FK-506. | Q33993452 | ||
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. | Q33993531 | ||
FK 506 for liver, kidney, and pancreas transplantation | Q34252199 | ||
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. | Q34275070 | ||
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. | Q34942525 | ||
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. | Q37175908 | ||
Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage | Q41056811 | ||
FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG | Q41765997 | ||
THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. | Q42219748 | ||
Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats | Q43900523 | ||
Studies of the effects of FK506 on renal allografting in the beagle dog. | Q45126785 | ||
Observations of orthotopic liver transplantation in the pig | Q54137294 | ||
Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation | Q69002726 | ||
Heterotopic heart transplantation in the rat receiving FK-506 | Q69009057 | ||
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro | Q69010285 | ||
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity | Q69054997 | ||
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2 | Q69055001 | ||
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes | Q69079614 | ||
Renal transplantation in baboons under FK 506 | Q69092046 | ||
Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat | Q69135605 | ||
Improved technique of heart transplantation in rats | Q69867057 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 186-189 | |
P577 | publication date | 1990-08-01 | |
P1433 | published in | Transplantation | Q15730500 |
P1476 | title | Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy | |
P478 | volume | 50 |
Q34498286 | A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results |
Q71672283 | A protocol with FK 506 for inducing unresponsiveness to murine islet allografts |
Q41662679 | A short course of FK506 can induce limited donor-specific graft acceptance |
Q73219472 | A successful induction of tolerance by perioperative intrathymic injection in rat "high-responder" heart transplantation |
Q35253580 | Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction |
Q34187736 | Adverse effects associated with the use of FK 506 |
Q34470498 | An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders |
Q34241674 | Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance |
Q34178622 | Cell migration, chimerism, and graft acceptance |
Q71695988 | Changes in the mononuclear cell subpopulations of rat cardiac transplant recipients administered FK506 for the treatment of ongoing rejection |
Q45892648 | Comparative studies of the effects of FK506 and cyclosporin A on passively transferred collagen-induced arthritis in rats |
Q34197027 | Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls |
Q34204368 | Current status of FK 506 in liver transplantation |
Q33612327 | Cyclic AMP prolongs graft survival by suppressing apoptosis and inflammatory gene expression in acute cardiac allograft rejection |
Q34237899 | Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression |
Q73033656 | Effect of a single injection of high-dose FK506 on lung transplantation in rats |
Q71627745 | Experimental rat pancreas transplant: surgical technique and immunological considerations |
Q34207851 | FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats |
Q36614950 | FK 506: an immunosuppressant for the 1990s? |
Q40491507 | FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects |
Q34207804 | FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats |
Q73984402 | Immunosuppression in auxiliary partial liver transplantation with FK506 in rats |
Q71627747 | Limited effectiveness of FK506 administration for ongoing rejection in heterotopic rat heart transplantation |
Q34281142 | Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats |
Q35605951 | Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat |
Q41888677 | Orthotopic liver transplantation in the mouse |
Q42719296 | Overview of FK506 in transplantation |
Q71619744 | Peripheral blood and intrahepatic subsets of T lymphocyte activation and function in liver allograft rejection and drug-induced tolerance in rats |
Q34286877 | Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. |
Q34275901 | Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors |
Q67531765 | Renal transplantation for the nephrologist: new immunosuppressive drugs |
Q40390963 | Tacrolimus, a new immunosuppressant--a review of the literature |
Q40385566 | Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation |
Q45060105 | The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents |
Q36686159 | The immunosuppressive macrolides FK-506 and rapamycin |
Q98222297 | Understanding, predicting and achieving liver transplant tolerance: from bench to bedside |
Q34357964 | Xenobiotics, chimerism and the induction of tolerance following organ transplantation |
Q53014428 | [Immunologic tolerance after experimental liver transplantation]. |